Ardelyx, Inc.
ARDXBiotechnologyOutlook Avoid, next 6 months
$3.03−2.26%As of Oct 30vs prior close
- Market cap
- $782.3M
- P/E (TTM)
- –
- Implied growth
- –
- From 52W high
- −62.08%
- EPS (LTM)
- -$0.23
- Revenue (LTM)
- $450.9M
- Net margin
- -12.35%
- Dividend yield
- 0.00%
Nomior Score
46
Anchored CompounderSpeculativeBottom 41% of the scored universe
Growth70
Quality67
Value55
Momentum9
Resilience41
Growth
+32.84%revenue a year over 8 fiscal years
YE17 $42MLTM $450.9M
Connections
Revenue to profitQ2 YE26
The operating loss was 10% of revenue, narrower by 4 pts on a year.
Who owns it
2funds